Oramed Pharmaceuticals (ORMP) Other Gross PP&E Adjustments (2022 - 2025)
Oramed Pharmaceuticals (ORMP) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with -$486000.0 as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Other Gross PP&E Adjustments rose 38.87% year-over-year to -$486000.0, compared with a TTM value of -$486000.0 through Sep 2024, up 38.87%, and an annual FY2023 reading of -$814000.0, up 21.5% over the prior year.
- Other Gross PP&E Adjustments was -$486000.0 for Q3 2024 at Oramed Pharmaceuticals, up from -$566000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$486000.0 in Q3 2024 and bottomed at -$1.4 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 3 years is -$925545.5, with a median of -$1.0 million recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments grew 12.98% in 2023, then soared 46.55% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$1.0 million in 2022, then rose by 21.5% to -$814000.0 in 2023, then skyrocketed by 40.29% to -$486000.0 in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for ORMP at -$486000.0 in Q3 2024, -$566000.0 in Q2 2024, and -$608000.0 in Q1 2024.